http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100426346-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
filingDate 2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100426346-B1
titleOfInvention Pharmaceutical compositions for Hypercholesterolemia treatment using of Self Emulsifying drug delivery system
abstract The present invention relates to a pharmaceutical composition for treating hyperlipidemia using a self-emulsifying drug delivery system, and more particularly, to improve the bioavailability of poorly soluble hyperlipidemia treatment agent having high hydrophobicity and crystallinity Formulated with a predetermined surfactant, a dissolving agent, and a co-surfactant to prepare a nanoemulsion concentrate, and when the drug is administered to a human body, a nanoemulsion is formed by digestive or bodily fluids to greatly improve the bioabsorption of the drug. The present invention relates to a pharmaceutical composition for treating hyperlipidemia using a self-microemulsifying drug delivery system in which a drug is completely solubilized to be administered in a liquid state as a concept of a drug delivery system.
priorityDate 2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20000006503-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0670715-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5993858-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20000020211-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53630264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425563244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534001
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID512563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420229795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450600746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079355
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID512563
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13296868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456987448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448881833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506484

Total number of triples: 46.